首页
400-620-6333
应用
选项
-
Recombinant Human VEGFR2/KDR Protein种属: 人(Human) Accession #: P35968表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by its ability to inhibit the VEGF-dependent proliferation of HUVEC human umbilical vein endothelial cells. The ED50 for this effect is 0.297 μg/mL in the presence of 8.0 ng/mL Recombinant Human VEGF (rp155965).
-
Recombinant Human ICAM-1/CD54 Protein种属: 人(Human) Accession #: P05362表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of 5 μg/mL PHA-stimulated human Jurkat T lymphocyte leukemia cell for 2h. The ED50 for this effect is 0.1892 μg/mL.
-
Recombinant Human MAdCAM-1 Protein种属: 人(Human) Accession #: Q4PKD0表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of Jurkat human T-lymphocyte leukemia cells in the presence of 1.0 mM MnCl2, The ED50 for this effect is 2.19 μg/mL.
-
Recombinant Human Cathepsin B Protein种属: 人(Human) Accession #: P07858表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human Cathepsin B Protein (rp183609) at 1.0 μg/mL can bind Cathepsin B Mouse mAb (Ab093155) with the EC50 of 163.1 ng/mL.
-
Recombinant Human PDGF R alpha Protein种属: 人(Human) Accession #: P16234表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human PDGF R alpha Protein (rp181613) at 1.0 μg/mL can bind Olaratumab (anti-PDGFRA) (Ab176458) with the EC50 of 17.27 ng/mL.
-
Recombinant Human IL-6R alpha Protein种属: 人(Human) Accession #: P08887表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human IL-6R alpha Protein (rp181252) at 2.0 μg/mL can bind Recombinant Human IL-6 Protein (rp156005) with the EC50 of 43.35 ng/mL. 2. Immobilized Recombinant Human IL-6R alpha Protein (rp181252) at 1.0 μg/mL can bind Vobarilizumab (anti-IL-6Ra) (Ab175700) with the EC50 of 67.99 ng/mL. 3. Immobilized Recombinant Human IL-6R alpha Protein (rp181252) at 1.0 μg/mL can bind Tocilizumab (anti-IL-6R) (T412004) with the EC50 of 21.05 ng/mL.
-
Recombinant Human CD30/TNFRSF8 Protein种属: 人(Human) Accession #: P28908表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human CD30 Protein (rp169577) at 1.0 μg/mL can bind Brentuximab (anti-TNFRSF8) (Ab170548) with the EC50 of 119.9 ng/mL.
-
Recombinant Human VISTA/B7-H5 Protein种属: 人(Human) Accession #: Q9H7M9表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human VISTA/B7-H5/PD-1H Protein (rp181308) at 1.0 μg/mL can bind Onvatilimab (anti-VISTA) (Ab170685) with the EC50 of 48.93 ng/mL.
-
Recombinant Human uPAR Protein种属: 人(Human) Accession #: Q03405表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Testing in progress
-
Recombinant Human ErbB3/HER3 Protein种属: 人(Human) Accession #: P21860表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Barecetamab (anti-ERBB3) (Ab182928) with the EC50 of 14.55 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Lumretuzumab (anti-ERBB3) (Ab182754) with the EC50 of 31.62 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Seribantumab (anti-ERBB3) (Ab175653) with the EC50 of 17.20 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Patritumab (anti-ERBB3) (Ab170705) with the EC50 of 27.08 ng/mL.
-
Recombinant Human CD79B Protein种属: 人(Human) Accession #: P40259表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL. 2. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
-
Recombinant Human IL-17A/F Heterodimer Protein种属: 人(Human) Accession #: Q16552,Q96PD4表达系统: HEK293 蛋白标签: C-His (IL17F) 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to induce IL-6 secretion by NIH‑3T3 mouse embryonic fibroblast cells. The ED50 for this effect is 0.4‑2 ng/mL.
